Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.
Saved in:
| Title: | Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection. |
|---|---|
| Authors: | Williams BG; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Barrett JR; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Scott JB; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Rigby CA; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Cagiada M; Department of Statistics, University of Oxford, Oxford, UK; Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark., Quinkert D; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., McHugh K; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Huhn A; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Burnap SA; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Gourjault C; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Byrne F; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Raghavan SSR; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Rodrigues A; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Bergamaschi L; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Balzarotti B; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Watson S; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Miller N; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., King LDW; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Donnellan FR; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Gladstone CA; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Paterson J; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Scalabrino S; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Silk SE; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Salkeld J; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Minassian AM; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Skinner K; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Struwe WB; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Deane CM; Department of Statistics, University of Oxford, Oxford, UK., Reece ST; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Draper SJ; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: simon.draper@paediatrics.ox.ac.uk. |
| Source: | Immunity [Immunity] 2026 Jun 12. Date of Electronic Publication: 2026 Jun 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42285102 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Williams+BG%22">Williams BG</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Barrett+JR%22">Barrett JR</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Scott+JB%22">Scott JB</searchLink>; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Rigby+CA%22">Rigby CA</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Cagiada+M%22">Cagiada M</searchLink>; Department of Statistics, University of Oxford, Oxford, UK; Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Quinkert+D%22">Quinkert D</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22McHugh+K%22">McHugh K</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Huhn+A%22">Huhn A</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Burnap+SA%22">Burnap SA</searchLink>; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Gourjault+C%22">Gourjault C</searchLink>; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Byrne+F%22">Byrne F</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Raghavan+SSR%22">Raghavan SSR</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rodrigues+A%22">Rodrigues A</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Bergamaschi+L%22">Bergamaschi L</searchLink>; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Balzarotti+B%22">Balzarotti B</searchLink>; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Watson+S%22">Watson S</searchLink>; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Miller+N%22">Miller N</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22King+LDW%22">King LDW</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Donnellan+FR%22">Donnellan FR</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Gladstone+CA%22">Gladstone CA</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Paterson+J%22">Paterson J</searchLink>; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Scalabrino+S%22">Scalabrino S</searchLink>; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Silk+SE%22">Silk SE</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Salkeld+J%22">Salkeld J</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Minassian+AM%22">Minassian AM</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Skinner+K%22">Skinner K</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Struwe+WB%22">Struwe WB</searchLink>; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Deane+CM%22">Deane CM</searchLink>; Department of Statistics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Reece+ST%22">Reece ST</searchLink>; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ward+AB%22">Ward AB</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Draper+SJ%22">Draper SJ</searchLink>; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: simon.draper@paediatrics.ox.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229432918%22">Immunity</searchLink> [Immunity] 2026 Jun 12. <i>Date of Electronic Publication: </i>2026 Jun 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9432918 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-4180 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210747613%22">10747613 </searchLink><i>NLM ISO Abbreviation: </i>Immunity <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42285102 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.immuni.2026.05.012 Languages: – Code: eng Text: English Titles: – TitleFull: Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Williams BG – PersonEntity: Name: NameFull: Barrett JR – PersonEntity: Name: NameFull: Scott JB – PersonEntity: Name: NameFull: Rigby CA – PersonEntity: Name: NameFull: Cagiada M – PersonEntity: Name: NameFull: Quinkert D – PersonEntity: Name: NameFull: McHugh K – PersonEntity: Name: NameFull: Huhn A – PersonEntity: Name: NameFull: Burnap SA – PersonEntity: Name: NameFull: Gourjault C – PersonEntity: Name: NameFull: Byrne F – PersonEntity: Name: NameFull: Raghavan SSR – PersonEntity: Name: NameFull: Rodrigues A – PersonEntity: Name: NameFull: Bergamaschi L – PersonEntity: Name: NameFull: Balzarotti B – PersonEntity: Name: NameFull: Watson S – PersonEntity: Name: NameFull: Miller N – PersonEntity: Name: NameFull: King LDW – PersonEntity: Name: NameFull: Donnellan FR – PersonEntity: Name: NameFull: Gladstone CA – PersonEntity: Name: NameFull: Paterson J – PersonEntity: Name: NameFull: Scalabrino S – PersonEntity: Name: NameFull: Silk SE – PersonEntity: Name: NameFull: Salkeld J – PersonEntity: Name: NameFull: Minassian AM – PersonEntity: Name: NameFull: Skinner K – PersonEntity: Name: NameFull: Struwe WB – PersonEntity: Name: NameFull: Deane CM – PersonEntity: Name: NameFull: Reece ST – PersonEntity: Name: NameFull: Ward AB – PersonEntity: Name: NameFull: Draper SJ IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 06 Text: 2026 Jun 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1097-4180 Titles: – TitleFull: Immunity Type: main |
| ResultId | 1 |